Saturday, July 11, 2026

Drug profile · INN

sulthiame

sulthiame (OSPOLOT) is a carbonic anhydrase inhibitor.

TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sulthiame
Class
Route
Patents
0
Programs
0
Data quality
0.78

Quick answer

sulthiame (OSPOLOT) is a carbonic anhydrase inhibitor.

Key facts

INN sulthiame
Brand OSPOLOT
Mechanism Carbonic anhydrase inhibitor
Target Carbonic anhydrase

Mechanism of action

Carbonic anhydrase inhibitor

Primary target: Carbonic anhydrase

Approval history

Authority Status Date
TGA approved

Related & competitor drugs

  1. acetazolamide Carbonic anhydrase XII inhibitor
  2. acetazolamide sodium Carbonic anhydrase XII inhibitor
  3. dichlorphenamide Carbonic anhydrase XII inhibitor
  4. dorzolamide hydrochloride Carbonic anhydrase II inhibitor
  5. methocarbamol Carbonic anhydrase I inhibitor
  6. topiramate GABA-A receptor; anion channel positive modulator

Frequently asked questions

What is sulthiame?

sulthiame (OSPOLOT) is a carbonic anhydrase inhibitor.

What is the brand name for sulthiame?

OSPOLOT is a marketed brand name for sulthiame. Check FDA Drugs@FDA for the current US label holder and prescribing information.